NDC properties for NDC 9 0185-0757
NDC item 00185075701
NDC 9 | 0185-0757 |
---|---|
NDC 10 | 0185-0757-01 |
NDC Item | 00185075701 |
packaging | 100 TABLET in 1 BOTTLE (0185-0757-01) |
ANDA | ANDA040091 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 578135 |
Imprint code | E757 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-05-31 |
Marketing effective time low | 1994-07-29 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 17 mm |
NDC item 00185075710
NDC 9 | 0185-0757 |
---|---|
NDC 10 | 0185-0757-10 |
NDC Item | 00185075710 |
packaging | 1000 TABLET in 1 BOTTLE (0185-0757-10) |
ANDA | ANDA040091 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 578135 |
Imprint code | E757 |
Labeler | Sandoz Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2024-05-31 |
Marketing effective time low | 1994-07-29 |
Marketing status | COMPLETED |
Score | 1 |
Shape | C48336 |
Size | 17 mm |
NDC item 42806075760
NDC 9 | 42806-757 |
---|---|
NDC 10 | 42806-757-60 |
NDC Item | 42806075760 |
packaging | 60 TABLET in 1 BOTTLE (42806-757-60) |
ANDA | ANDA040091 |
COLORTEXT | WHITE |
Color | C48325 __ |
FDA SPL set id | 756292 |
Imprint code | E757 |
Labeler | EPIC PHARMA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2021-12-15 |
Marketing status | ACTIVE |
Score | 1 |
Shape | C48336 |
Size | 17 mm |
NDC item 62135084260
NDC 9 | 62135-842 |
---|---|
NDC 10 | 62135-842-60 |
NDC Item | 62135084260 |
packaging | 60 TABLET in 1 BOTTLE (62135-842-60) |
ANDA | ANDA080084 |
COLORTEXT | white |
Color | C48325 __ |
FDA SPL set id | 811762 |
Imprint code | CE;208 |
Labeler | Chartwell RX, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-09-23 |
Marketing status | ACTIVE |
Score | 2 |
Shapetext | bevel edged |
Shape | C48348 |
Size | 13 mm |